Deepak Fertilisers & Petrochemicals Corp Ltd Q2 FY2026 Concall Summary

Key Takeaways

• Margins compressed but story intact: Operating EBITDA margin fell from 18% to 15% on global headwinds and ammonia pricing, yet TAN volumes grew 29% and Crop Nutrition 54%, showing underlying demand strength.
• The capex cycle is peaking, not breaking: Two major projects are 87% and 70% complete with commissioning on track for Q4 FY26, peak debt is guided to INR4,500 crores, and management explicitly plans to deleverage once spending rolls off.
• Ammonia is the swing factor: Prices troughed at an abnormal $300/MT and have already rebounded above $400; a new Equinor gas contract from May '26 plus a Q4 efficiency shutdown set up a material margin recovery that management declined to quantify.
• The specialty and B2C pivot is accelerating: Croptek grew 54% YoY, B2C TAN sales grew 33%, and specialty products now represent 35% of fertiliser revenue, but management refused to disclose the margin differential, calling it only "material."
• What to watch next quarter: Whether ammonia prices hold above $400, the pace of post-monsoon TAN demand recovery, and any government movement on GST incentive relief for the ammonia plant.

Margin Walk: What Hit the Quarter

• Headline compression: Operating EBITDA margin dropped 300 bps QoQ to 15%, driven by two concentrated pain points: ammonia and IPA. Every other business segment showed positive growth.
• Ammonia: a perfect storm. FOB Middle East prices averaged ~$300/MT, well below the 10-year average of $450+. Higher natural gas consumption from start-up/shut-down cycles, lower incentive income from a GST rate cut, and elevated gas rates compounded the pressure.
• IPA: global oversupply hit pricing. Volumes were flat YoY at 17 KT, but a steep drop in acetone and IPA prices plus a surge in US anti-dumping duties on China intensified competitive pressure in the domestic market.
• The rest of the portfolio held up. TAN ran at 100% capacity even through the monsoon, manufactured fertiliser volumes were down only because one raw material was in short supply (now resolved), and Croptek delivered 54% growth.
• Inventory build is seasonal, not structural. The Q2 spike reflects normal pre-Rabi and post-monsoon TAN inventory accumulation; management expects it to unwind.

Mehta: "Now prima facie Q2 results, in a sense, indicate a bit of tough going, looking at the operating EBITDA margins dropping from 18% to 15%, but it is essential to go a little deeper and granular to understand the true picture and the resilience the businesses have shown in the context of the global geopolitical headwinds."

Ammonia: The Turnaround Bet

• Price recovery underway. Ammonia prices troughed at ~$300/MT, which management calls an abnormality against a 10-year average of $450+. Prices have already rebounded above $400 and are normalizing.
• Equinor gas contract is the structural unlock. A new LNG contract with Equinor kicks in from May '26 and is expected to deliver a significant reduction in basket gas prices, bringing the ammonia plant's breakeven EBITDA level "much lower." Management declined to quantify the savings.
• Q4 shutdown adds capacity and efficiency. A planned shutdown of a few weeks in Q4 will deliver ~10% capacity increase and complete pending efficiency actions; the plant will be "far more efficient" afterward. The company will import ammonia during the outage so no business is disrupted.
• GST incentive relief is a wildcard. A GST rate cut reduced incentive income for the ammonia plant. Management is representing to government that the ultra-mega plant should not be penalized, but acknowledged "things take time" and is not banking on it: "We are ensuring our internal actions make us efficient to make money in this."
• PCL profitability should return. With the Equinor contract, firming ammonia prices, and efficiency gains from the shutdown, management expects the ammonia subsidiary to start making money again.

Anand: "If everything remains same where our gas prices are today, we expect significant reduction in our gas prices, basket gas prices to happen because of new contract. And that will bring down our breakeven EBITDA level for Ammonia much lower."

TAN: Full Capacity, Export Optionality, New Supply Coming

• Demand is running ahead of capacity. The TAN plant operated at 100% utilisation even through the monsoon, a seasonally slow period. Domestic demand absorbed all production; no excess capacity was available for export.
• Export quota reinstated and delivering. The export quota was enhanced to 50,000 metric tons per year in June 2025 after a gap of a couple of years. Q1 was a washout; Q2 began showing results. Target geographies are South Asia, Southeast Asia, and the Middle East, with Australia becoming viable once Gopalpur is online.
• Export vs domestic is a margin call, not a volume call. Management prioritizes the domestic market as a commitment to India's self-reliance but will export when it makes financial sense. It declined to disclose the margin differential between export and domestic sales.
• Gopalpur adds 50%+ capacity. The new TAN project is 87% complete and on track for commissioning toward the end of Q4 FY26. Normal capacity utilisation is expected over a 3-year ramp: ~70% in FY27, 80%+ in FY28, full realisation by FY29.
• Russian imports are being contained. Management noted that Russian ammonium nitrate imports have been "a little bit controlled over the last 6 months" and that the government is realising domestic capacity will make India self-reliant.

Sinha: "See, if it was only to meet the volumes to satisfy the quota requirements, that is not a problem. But as a responsible company, what we have to keep in mind is that as long as it makes financial sense to export compared to what we can generate in the domestic market, then so be it."

Crop Nutrition & Specialty: The Mix Shift

• Croptek is scaling fast. The specialty crop nutrition brand delivered 54% YoY growth on strong market acceptance and farmer adoption. An above-normal monsoon provides a good foundation for Rabi demand.
• Manufactured volumes were down on input shortage, not demand. Bulk fertiliser manufacturing sales fell 31% YoY because one key raw material was in short supply, forcing a shift to trading imports. The raw material shortage has normalized and coverage is in place for coming quarters.
• Specialty products are now a disclosed, material line. Specialty products represent 35% of fertiliser revenue. PICKBRITE is showing promising results in stainless steel pickling trials, and Cororid has expanded to over 250 hospitals across 16 states.
• B2C penetration is deepening. B2C sales in TAN grew 33% YoY and now represent 14% of segment revenue. Management is focused on moving the portfolio toward specialty and value-added products but declined to quantify the margin differential or set internal accretion targets.
• Haifa collaboration continues. The long-term partnership with Haifa (Israel) is exploring products to bring into India and supporting local product development.

Capex, Debt & Capital Allocation

• The cycle is peaking. The two major projects (TAN Gopalpur at 87%, Nitric Acid Dahej at 70%) are on track for commissioning toward the end of Q4 FY26. The majority of remaining capex will be spent toward year-end, with 10-15% held back as performance guarantees.
• Peak debt is guided at INR4,500 crores. Management expects to hit this level toward the end of the current fiscal year.
• Deleveraging is the stated next move. In the absence of incremental capex or a suitable acquisition, cash flows will be used to pay down debt. No immediate new capex is planned; a cooling period is expected before the next cycle.
• Asset turns and ramp-up. The two new plants are expected to deliver asset turns of roughly 0.5-0.6, with a normal 3-year ramp to full capacity utilisation by FY29. Management declined to provide ROCE figures.
• Platinum Blasting Services acquisition closed. The Australian subsidiary was acquired at 6.7x EBITDA for an enterprise value of INR537 crores, adding forward integration into mining solutions across Australia and India.
• CWIP reconciliation was not fully answered. An analyst noted that CWIP (INR2,200 crores) is well below total estimated capex (INR4,650 crores) with plants ~6 months from commissioning. Management cited phasing and performance guarantees but did not reconcile the specific gap.

IPA & Industrial Chemicals: Waiting on Stabilisation

• Pricing, not volume, is the problem. IPA volumes were flat YoY at 17 KT, but a sharp decline in acetone and IPA prices compressed margins. Global oversupply and a surge in US anti-dumping duties on China intensified competitive pressure in the domestic market.
• Early signs of stabilisation. Management is encouraged by early signs of price stabilisation driven by global trade realignment and sanctions. The company is actively pursuing pharma-grade export and technical-grade applications alongside cost optimisation.
• Nitric Acid prices are expected to remain stable, influenced by increased imports. The new Nitric Acid project at Dahej (70% complete) will add capacity toward the end of Q4 FY26.

Guidance & Commitments

Key Metrics